Diabetes drug tested as potential new tool to fight alcohol cravings
NCT ID NCT06727331
Summary
This small pilot study is testing whether tirzepatide, a medication currently used for diabetes and weight loss, might help people with alcohol use disorder. Twenty participants will receive weekly injections of either the drug or a placebo for four weeks. Researchers will measure changes in alcohol cravings, drinking behavior, and safety to see if this approach is worth studying in larger trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Faulkner Hospital
RECRUITINGJamaica Plain, Massachusetts, 02130, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Brigham and Women's Hospital
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.